Whole-gland salvage treatment for recurrent prostate cancer after initial definitive radiotherapy: A case series of 125I brachytherapy and robot-assisted radical prostatectomy
Authors:
Open Access
- 1 January 2019
- journal article
- research article
- Published by Termedia Sp. z.o.o. in Journal of Contemporary Brachytherapy
- Vol. 11 (3) , 201-206
Abstract
Purpose To analyze outcomes following whole-gland salvage treatments applied to patients with pathology-proven, locally recurrent prostate cancer following primary definitive radiotherapy. Material and methods Eighteen consecutive patients who received whole-gland salvage treatments at our...Keywords
This publication has 19 references indexed in Scilit:
- Rectal dose constraints for salvage iodine-125 prostate brachytherapyBrachytherapy, 2016
- Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: Association between dose and late toxicityBrachytherapy, 2015
- Permanent prostate brachytherapy with or without supplemental external beam radiotherapy as practiced in Japan: Outcomes of 1300 patientsBrachytherapy, 2015
- Salvage brachytherapy for recurrent prostate cancerBrachytherapy, 2014
- Seminal vesicle involvement at salvage radical prostatectomyBJU International, 2013
- Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer: A Multi-institutional CollaborationEuropean Urology, 2011
- Long-Term Outcome and Toxicity of Salvage Brachytherapy for Local Failure After Initial Radiotherapy for Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Treatment outcome and toxicity after salvage 125-I implantation for prostate cancer recurrences after primary 125-I implantation and external beam radiotherapyBrachytherapy, 2010
- Salvage permanent perineal radioactive‐seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapyBJU International, 2009
- Magnetic resonance image‐guided salvage brachytherapy after radiation in select men who initially presented with favorable‐risk prostate cancerCancer, 2007